New England Journal of Medicine· 2019Q1
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
- 3,618citations
- Q1SCImago
- 2019year
Short summary
Transcatheter aortic-valve replacement (TAVR) with a self-expanding bioprosthesis is non-inferior to surgical aortic-valve replacement in low-risk patients with severe aortic stenosis, showing comparable rates of death or disabling stroke at 24 months.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine